HomeREGULATORY
REGULATORY

“Drug Value Assessments Will Be Critical”; High-Priced Innovative Drugs to Be a Topic at OECD Meeting: Health Minister
(Jan.10.2017)

Health Minister Yasuhisa Shiozaki
Health Minister Yasuhisa Shiozaki stressed on January 6 that “how to assess the value of drugs will be a critical issue” going forward. Revealing that the pricing of expensive but effective drugs will be discussed at a meeting of OECD health ministers later this month in Paris, he said he plans to take this question up “as an extremely important issue.”...
(LOG IN FOR FULL STORY)

News Calendar